Business

TOKYO (Reuters) – Asian stocks took a breather on Wednesday, with mounting signs of slowing global growth and concerns over a yet-unresolved Sino-U.S. trade dispute putting the brakes on investor appetite for risk assets. FILE PHOTO: A man looks at a stock quotation board outside a brokerage in Tokyo, Japan, April 18, 2016. REUTERS/Toru Hanai
0 Comments
TOKYO (Reuters) – Asian stocks edged down on Wednesday on mounting signs of slowing global growth and anxiety over a yet-unresolved Sino-U.S. trade dispute. A man looks at a stock quotation board outside a brokerage in Tokyo, Japan, April 18, 2016. REUTERS/Toru Hanai Japan’s Nikkei .N225 dropped 0.7 percent while MSCI’s broadest index of Asia-Pacific
0 Comments
(Reuters) – Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts’ estimates and said it expected further pressure on U.S. prescription drug prices, weighing on the broader pharmaceutical sector. A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake J&J, the first major drugmaker to
0 Comments
Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., January 22, 2019. REUTERS/Brendan McDermid NEW YORK (Reuters) – U.S. stocks ended lower on Tuesday, snapping a four-session rally, as a gloomy global economic growth outlook, trade concerns and disappointing company forecasts dampened sentiment. Based on the latest available
0 Comments
LONDON (Reuters) – James Dyson, the billionaire Brexit supporter who revolutionized vacuum cleaners with his bagless technology, is moving his head office to Singapore from Britain to be closer to his company’s fastest-growing markets. FILE PHOTO: Dyson CEO Jim Rowan speaks during a product launch event in Beijing, China September 12, 2018. REUTERS/Damir Sagolj/File Photo
0 Comments
(Reuters) – Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts’ estimates as the healthcare conglomerate faces increasing competition for some of its older drugs. A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake The company’s prostate cancer drug Zytiga, an important growth driver,
0 Comments
WASHINGTON (Reuters) – U.S. home sales tumbled to their lowest level in three years in December and house price increases slowed sharply, suggesting a further loss of momentum in the housing market. FILE PHOTO – A sold sign hangs in front of a house in Dallas, Texas September 24, 2009. REUTERS/Jessica Rinaldi The National Association
0 Comments
ZURICH (Reuters) – UBS (UBSG.S) warned of a tough start to 2019, after reporting an outflow of funds from its flagship wealth management business at the end of last year, sending a shiver through the European banking sector. FILE PHOTO: The logo of Swiss bank UBS is seen in Zurich, Switzerland October 25, 2018. REUTERS/Arnd
0 Comments
Mastercard Inc. credit cards are displayed in this picture illustration taken December 8, 2017. REUTERS/Benoit Tessier/Illustration BRUSSELS (Reuters) – The European Commission said on Tuesday it had fined Mastercard (MA.N) 570.6 million euros ($648.3 million) for limiting the possibility for merchants to benefit from better conditions offered by banks elsewhere in the European Union. “By
0 Comments